Regulon

Regulon: R-2556

Regulons are regulatory units consisting of a coherently expressed set of genes and the associated regulator(s) whose binding site(s) they share.

Regulon Summary

Regulon summary table displays all associated information related to the specific regulon including the number of genes in the regulon, Hazard ratio, its Regulator, the Transcriptional Program that includes the regulon, Drugs that are associated with members of the regulon, together with mechanism of action and class, and enriched hallmarks of cancer if any.

GenesCox Hazard RatioRegulatorsCausal FlowsTranscriptional ProgramsHallmarks
150.09869310Pr-146Self sufficiency in growth signalInsensitivity to antigrowth signalEvading apoptosisSustained angiogenesisTissue invasion and metastasisTumor-promoting inflammationReprogramming energy metabolismEvading immune detectionLimitless replicative potentialGenome instability and mutation

Regulon Genes

List of genes that are included in the regulon. These genes have similar expression profiles in subset of patients and they share common binding motif for the Regulator of the regulon. Clicking on the gene name will take you to the gene specific page with more details. Please wait while information is collated from several resources after you click.

Entrez IDEnsEMBL IDPreferred NameUniprot ID
5434 ENSG00000099817 POLR2E P19388
4174 ENSG00000100297 MCM5 P33992
10295 ENSG00000103507 BCKDK O14874
10938 ENSG00000110047 EHD1 B2R5U3
79080 ENSG00000110104 CCDC86 Q9H6F5
9469 ENSG00000122863 CHST3 Q7LGC8
22913 ENSG00000125970 RALY Q9UKM9
11047 ENSG00000130706 ADRM1 Q16186
5914 ENSG00000131759 RARA A8MUP8
3159 ENSG00000137309 HMGA1 P17096
79759 ENSG00000167394 ZNF668 A0A024QZD9
26000 ENSG00000169221 TBC1D10B Q4KMP7
10589 ENSG00000175550 DRAP1 Q14919
79050 ENSG00000184967 NOC4L Q9BVI4
10072 ENSG00000254986 DPP3 G3V1D3

Regulon Drugs

NameApproved SymbolTypeAction TypeMechanism of ActionMax Trial PhaseMax GBM Phase
TAZAROTENERARGSmall moleculeAGONISTRetinoic acid receptor agonist40
OPROZOMIBPSMD1Small moleculeINHIBITOR26S proteosome inhibitor10
NRX195183RARASmall moleculeAGONISTRetinoic acid receptor alpha agonist20
IXAZOMIBPSMD1Small moleculeINHIBITOR26S proteasome inhibitor40
TAMIBAROTENERARASmall moleculeAGONISTRetinoic acid receptor alpha agonist20
ADAPALENERARGSmall moleculeAGONISTRetinoic acid receptor agonist40
ETRETINATERARGSmall moleculeAGONISTRetinoid receptor agonist40
ISOTRETINOINRARGSmall moleculeAGONISTRetinoic acid receptor agonist41
BORTEZOMIBPSMD1Small moleculeINHIBITOR26S proteosome inhibitor41
ACITRETINRARGSmall moleculeAGONISTRetinoid receptor agonist40
ALITRETINOINRARGSmall moleculeAGONISTRetinoid receptor agonist40
IXAZOMIB CITRATEPSMD1Small moleculeINHIBITOR26S proteosome inhibitor40
TRETINOINRARGSmall moleculeAGONISTRetinoic acid receptor agonist40
CARFILZOMIBPSMD1ProteinINHIBITOR26S proteosome inhibitor40

Causal Flows

Causal Flows are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators and regulons. In the causal flow a mutation may causally activates or deactivates a downstream regulator which then might up- or down-regulates a regulon that contains genes with similar expression profiles and binding sites.

Causal Mechanistic Flows for Regulon R-2556

IDMutationRoleRegulatorRoleRegulon# downstream regulons# diffexp regulonsDrugs